But randomised controlled trials are needed to confirm these findings Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes might prevent dementia, providing greater benefits with longer treatment, suggests a large study from Korea published by The BMJ today. As this study was observational, the researchers note that the effect size ...
High dose psilocybin was the only psychedelic treatment to reduce depressive symptoms by more than placebo in antidepressant trials High doses of psilocybin - the active ingredient in magic mushrooms - appears to have a similar effect on depressive symptoms as the selective serotonin reuptake inhibitor (SSRI) drug escitalopram, suggests ...
Results highlight ongoing need for research and prevention efforts among doctors, particularly women Suicide rates among doctors have declined over time, but are still significantly higher for female doctors compared with the general population, finds an analysis of evidence from 20 countries published by The BMJ today. The researchers acknowledge that physician ...
Associations held after factoring in diabetes and limiting age of first stroke up to 40 Assessments beyond traditional stroke risk factors now needed, suggest researchers A lower level of mental ability during the teenage years may be linked to as much as a tripling in the risk of having a ...
Nearly 1 in 4 say gambling has affected their personal/professional lives over past year Better, earlier, and targeted support needed, urge researchers Several indicative factors, including junior rank, male sex, and younger age, are strongly linked to ‘harmful gambling’ among serving UK military personnel, finds an analysis of survey responses, ...
The BMJ Press Notice: Monday 10 February 2025 Correction to research paper: Efficacy of psilocybin for treating symptoms of depression A correction has been made to a research paper published by The BMJ on 1 May 2024: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. Overall, ...
Risks highest soon after starting drugs, underscoring need for increased caution in early stages of treatment, say experts Antipsychotic use in people with dementia is associated with elevated risks of a wide range of serious adverse outcomes including stroke, blood clots, heart attack, heart failure, fracture, pneumonia, and acute kidney ...
Sweet spot seems to be 0.68 mg/day among healthy older people to ward off decline Optimal maintenance dose seems to be 0.6 to less than 1 mg/day There seems to be a J-shaped curve between dietary thiamine (vitamin B1) and worsening mental acuity among cognitively healthy older people, suggests research ...
Women’s health cannot be allowed to be hijacked by vested interests, say experts Feminist health narratives are being co-opted by commercial interests to market new technologies, tests, and treatments that are not backed by evidence, argue researchers in The BMJ today. Dr Tessa Copp at The University of Sydney and colleagues say ...
Even low intensity activities are beneficial, but the more vigorous the activity, the greater the benefits Walking or jogging, yoga, and strength training seem to be the most effective exercises to ease depression, either alone or alongside established treatments such as psychotherapy and drugs, suggests an evidence review published by The ...
Copyright © 2025 BMJ Publishing Group Limited. All rights reserved.
Cookie settings | Accessibility | Cookie policy | Modern Slavery Statement | Privacy policy | Website terms and conditions
